Table 4:
Variables | Asthma/COPD Overlap vs. Neither |
Isolated-Asthma vs. Neither |
Isolated-COPD vs. Neither |
||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | HR | 95% CI | p | |
IgEc | 2.31 | 1.14–4.67 | 0.02d | 1.21 | 0.92–1.58 | 0.16 | 1.14 | 0.81–1.62 | 0.45 |
IFN-γc | 0.42 | 0.22–0.81 | 0.01d | 0.48 | 0.32–0.70 | <0.001 | 0.45 | 0.28–0.70 | <0.001 |
IL-21c | 1.33 | 0.89–1.98 | 0.17 | 1.73 | 1.27–2.35 | <0.001 | 2.06 | 1.31–3.23 | 0.002 |
IL-4 substituted for IL-21 in Marginal Cox regression model | |||||||||
IL-4c | 1.51 | 1.17–1.95 | 0.002 | 1.68 | 1.08–2.61 | 0.02d | 1.35 | 0.96–1.91 | 0.08 |
N=215;
Adjusted for age, race, BMI, smoking status, WTC exposure level, first post 9/11 FEV1/FVC;
One log2 increase (doubling) of cytokine concentration.
A p value of 0.0024 was considered significant after bonferroni correction.